---
schema_version: "secwatch.filing_event.v1"
accession: "0001171843-26-001447"
form_type: "8-K"
ticker: "HBIO"
cik: "0001123494"
company_name: "HARVARD BIOSCIENCE INC"
filed_at: "2026-03-10T23:59:59+00:00"
generated_at: "2026-05-15T15:29:34.595061+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Harvard Bioscience amends CEO pay, appoints Frost as CFO with $375k base

## Summary
- CEO John Duke gets base salary $515k; $100k cash bonus tied to credit facility refinancing.
- CEO eligible for annual cash incentive up to 80% of base; target 75k RSUs post 1:10 reverse split.
- CFO Mark Frost appointed effective March 6, 2026; salary $375k, annual cash incentive up to 60%.
- Frost's target equity grant for 2026 is 30k RSUs post reverse split; agreements run through 2027.
- Reverse stock split (1:10) takes effect March 13, 2026 as previously announced.

## SEC filing metadata
- accession: 0001171843-26-001447
- form_type: 8-K
- ticker: HBIO
- cik: 0001123494
- company_name: HARVARD BIOSCIENCE INC
- filed_at: 2026-03-10T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1123494/000117184326001447/0001171843-26-001447-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1123494/000117184326001447/f8k_031026.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001171843-26-001447
- JSON: https://secwatch.observer/filing/0001171843-26-001447.json
- Plain text: https://secwatch.observer/filing/0001171843-26-001447.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.